@article{3179908,
    title = "Chemotherapy plus or minus bevacizumab for platinum-sensitive ovarian
cancer patients recurring after a bevacizumab containing first line
treatment: The randomized phase 3 trial MITO16B-MaNGO OV2B-ENGOT OV17",
    author = "Pignata, Sandro and Lorusso, Domenica and Joly, Florence and Gallo, Ciro and and Colombo, Nicoletta and Sessa, Cristiana and Bamias, Aristotelis and and Pisano, Carmela and Selle, Frederic and Zaccarelli, Eleonora and and Scambia, Giovanni and Pautier, Patricia and Nicoletto, Maria Ornella and and De Giorgi, Ugo and Dubot, Coraline and Bologna, Alessandra and Orditura, and Michele and Ray-Coquard, Isabelle Laure and Perrone, Francesco and and Daniele, Gennaro",
    journal = "World Journal of Clinical Oncology",
    year = "2018",
    volume = "36",
    number = "15, S",
    publisher = "AMER SOC CLINICAL ONCOLOGY 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA",
    doi = "10.1200/JCO.2018.36.15_suppl.5506"
}